Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May 3:15:53.
doi: 10.1186/s12890-015-0048-5.

Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling

Jacob H Kristensen  1   2 , Morten A Karsdal  3 , Jannie Mb Sand  4 , Nicholas Willumsen  5 , Claudia Diefenbach  6 , Birte Svensson  7 , Per Hägglund  8 , Diana J Oersnes-Leeming  9
Affiliations

Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling

Jacob H Kristensen et al. BMC Pulm Med. .

Abstract

Background: During the pathological destruction of lung tissue, neutrophil elastase (NE) degrades elastin, one of the major constituents of lung parenchyma. However there are no non-invasive methods to quantify NE degradation of elastin. We selected specific elastin fragments generated by NE for antibody generation and developed an ELISA assay (EL-NE) for the quantification of NE-degraded elastin.

Methods: Monoclonal antibodies were developed against 10 NE-specific cleavage sites on elastin. One EL-NE assay was tested for analyte stability, linearity and intra- and inter-assay variation. The NE specificity was demonstrated using elastin cleaved in vitro with matrix metalloproteinases (MMPs), cathepsin G (CatG), NE and intact elastin. Clinical relevance was assessed by measuring levels of NE-generated elastin fragments in serum of patients diagnosed with idiopathic pulmonary fibrosis (IPF, n = 10) or lung cancer (n = 40).

Results: Analyte recovery of EL-NE for human serum was between 85% and 104%, the analyte was stable for four freeze/thaw cycles and after 24 h storage at 4°C. EL-NE was specific for NE-degraded elastin. Levels of NE-generated elastin fragments for elastin incubated in the presence of NE were 900% to 4700% higher than those seen with CatG or MMP incubation or in intact elastin. Serum levels of NE-generated elastin fragments were significantly increased in patients with IPF (137%, p = 0.002) and in patients with lung cancer (510%, p < 0.001) compared with age- and sex-matched controls.

Conclusions: The EL-NE assay was specific for NE-degraded elastin. The EL-NE assay was able to specifically quantify NE-degraded elastin in serum. Serum levels of NE-degraded elastin might be used to detect excessive lung tissue degradation in lung cancer and IPF.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Characterization and Specificity of the EL-NE Monoclonal Antibody. (A): Competitive ELISA showing inhibition of free peptide (GGPGFGPGVV), elongated peptide (GGPGFGPGVVG), nonsense peptide (VGAGVPGLGV) and nonsense screening peptide (Biotin-KK- VGAGVPGLGV). (B): EL-NE fragment levels after 48 hours in vitro incubation of intact human elastin separately in buffer (ELN), elastin incubated in the presence of NE, MMP-2, MMP-7, MMP-9 and MMP-12. NE incubated for 48 hours separately in buffer was added as control. Abbreviations: ELN, elastin; NE, Neutrophil elastase; MMP, matrix metalloproteinase.
Figure 2
Figure 2
Cross-Reactivity to Cathepsin. EL-NE fragment levels after 24 hours in vitro incubation of intact human elastin separately in buffer (ELN) and elastin incubated with CatG and NE. EL-NE levels in NE and CatG separately in buffer are also shown. Abbreviations: ELN, elastin; NE, Neutrophil elastase; CatG, Cathepsin G.
Figure 3
Figure 3
Degradation of Elastin in IPF and lung cancer. (A): EL-NE fragment levels in serum from patients with IPF (n = 10) compared with controls (n = 9). ** p < 0.01. (B): EL-NE fragment levels in serum from patients diagnosed with lung cancer (n = 40 in total), SCC (n = 16), adenocarcinoma (n = 16) and SCLC (n = 8) compared with controls (n = 12). **** p < 0.0001. Groups were compared by T-test with Welch correction. Data are shown as the geometric mean (95% CI). Abbreviations: IPF, idiopathic pulmonary fibrosis; SCC, squamous cell carcinoma; SCLC, small cell lung carcinoma.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Karsdal MA, Nielsen MJ, Sand JM, Henriksen K, Genovese F, Bay-Jensen AC, Victoria S, Adamkewicz JI, Christiansen C, Leeming DJ: Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue Diseases Possibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, But a Key Player in Tissue Failure. Assay Drug Dev Technol 2012. - PMC - PubMed
    1. Konigshoff M. Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity. Respiration. 2011;81:353–8. doi: 10.1159/000326299. - DOI - PubMed
    1. King TE, Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378:1949–61. doi: 10.1016/S0140-6736(11)60052-4. - DOI - PubMed
    1. Kristensen JH, Karsdal MA, Genovese F, Johnson S, Svensson B, Jacobsen S, Hagglund P, Leeming DJ: The Role of Extracellular Matrix Quality in Pulmonary Fibrosis. Respiration 2014. - PubMed
    1. McKeown S, Richter AG, O'Kane C, McAuley DF, Thickett DR. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J. 2009;33:77–84. doi: 10.1183/09031936.00060708. - DOI - PubMed

Publication types